Trials / Completed
CompletedNCT00000336
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
Safety and Efficacy of Selegiline in Outpatient Treatment for Cocaine
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging, MRI) post-hoc as a possible variable for future stratification in clinical trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Selegiline |
Timeline
- Start date
- 1995-01-01
- Primary completion
- 1996-02-01
- Completion
- 1996-03-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000336. Inclusion in this directory is not an endorsement.